Concord Medical Services Holdings Limited cash flow to debt ratio of -5.55% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

Concord Medical Services Holdings Limited's free cash flow has increased -63.74% from $-808.58M last year to $-293.16M, signaling increasing performance

Concord Medical Services Holdings Limited's debt to equity ratio is -1.73, signaling that the company spent its equity and risk bankruptcy.

Concord Medical Services Holdings Limited's debt to equity ratio is -1.73, signaling that the company spent its equity and risk bankruptcy.

Concord Medical Services Holdings Limited has negative EBITDA, making leverage ratio unreliable

Concord Medical Services Holdings Limited's interest coverage ratio is -1.57, which means that the company struggles to meet interest obligations, signaling financial risk.

Concord Medical Services Holdings Limited's profit margin has increased (-73.53%) in the last year from -80.28% to -21.25%, signaling increasing performance

Concord Medical Services Holdings Limited's short-term liabilities of $1.95G exceed its short-term assets of $941.91M, signaling financial risk

Concord Medical Services Holdings Limited's return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

Concord Medical Services Holdings Limited's return on equity of 5.73%, is lower than 15.00%, indicating bad performance

Concord Medical Services Holdings Limited's operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

Concord Medical Services Holdings Limited had positive net income in only 0.00 out of 5 years, indicating unstable earnings

Concord Medical Services Holdings Limited has negative free cash flow, indicating the company is burning cash rather than generating it

Concord Medical Services Holdings Limited has negative free cash flow, indicating cash burn

Concord Medical Services Holdings Limited's yearly earnings has increased -69.89% since last year from $-308.24M to $-92.81M, signaling increasing performance

Concord Medical Services Holdings Limited's yearly revenue has increased 19.94% since last year from $383.96M to $460.51M, signaling increasing performance

ROIC -4.26% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

Concord Medical Services Holdings Limited's 3-year revenue CAGR of -0.82% is negative, indicating declining revenue over the past 3 years

Concord Medical Services Holdings Limited had revenue growth in 3.00 out of 5 years, indicating consistent revenue performance

Concord Medical Services Holdings Limited had positive ROE in only 0.00 out of 5 years, indicating inconsistent returns on equity

Concord Medical Services Holdings Limited has insufficient data to evaluate this check.

Concord Medical Services Holdings Limited has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Concord Medical Services Holdings Limited is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

Concord Medical Services Holdings Limited has negative or missing EBITDA, making EV/EBITDA ratio unreliable

Concord Medical Services Holdings Limited is overvalued relative to its fair value price of -57.77K based on Earnings Fair Value model

Concord Medical Services Holdings Limited has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Concord Medical Services Holdings Limited has negative shareholder equity; price-to-book is not meaningful and the check fails

Concord Medical Services Holdings Limited has a price-to-sales ratio of 0.00x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue